Global Medicinal Radiocompounds Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Medicinal Radiocompounds market size was valued at USD 6956.7 million in 2023 and is forecast to a readjusted size of USD 11810 million by 2030 with a CAGR of 7.8% during review period.

Medicinal Radiocompounds refer to a class of special medicines containing radionuclides for medical diagnosis and treatment. Compounds or biological preparations containing radionuclide labels used for medical diagnosis or treatment in the body. Medicinal Radiocompounds are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Medicinal Radiocompounds industry chain, the market status of Oncology (Technetium 99, Fluorine 18), Cardiology (Technetium 99, Fluorine 18), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Medicinal Radiocompounds.

Regionally, the report analyzes the Medicinal Radiocompounds markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Medicinal Radiocompounds market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Medicinal Radiocompounds market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Medicinal Radiocompounds industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Tons), revenue generated, and market share of different by Type (e.g., Technetium 99, Fluorine 18).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Medicinal Radiocompounds market.

Regional Analysis: The report involves examining the Medicinal Radiocompounds market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Medicinal Radiocompounds market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Medicinal Radiocompounds:
Company Analysis: Report covers individual Medicinal Radiocompounds manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Medicinal Radiocompounds This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Oncology, Cardiology).

Technology Analysis: Report covers specific technologies relevant to Medicinal Radiocompounds. It assesses the current state, advancements, and potential future developments in Medicinal Radiocompounds areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Medicinal Radiocompounds market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Medicinal Radiocompounds market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
    Technetium 99
    Fluorine 18
    Other

Market segment by Application
    Oncology
    Cardiology
    Others

Major players covered
    Bracco Imaging
    Bayer
    Cardinal Health
    Curium Pharma
    Novartis
    Lantheus
    Acrotech Biopharma
    GE Healthcare
    China Isotope & Radiation
    Jubilant Pharma
    Eli Lilly
    SIEMENS
    Dongcheng

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Medicinal Radiocompounds product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Medicinal Radiocompounds, with price, sales, revenue and global market share of Medicinal Radiocompounds from 2019 to 2024.
Chapter 3, the Medicinal Radiocompounds competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medicinal Radiocompounds breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Medicinal Radiocompounds market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Medicinal Radiocompounds.
Chapter 14 and 15, to describe Medicinal Radiocompounds sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Medicinal Radiocompounds
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Medicinal Radiocompounds Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Technetium 99
        1.3.3 Fluorine 18
        1.3.4 Other
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Medicinal Radiocompounds Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Oncology
        1.4.3 Cardiology
        1.4.4 Others
    1.5 Global Medicinal Radiocompounds Market Size & Forecast
        1.5.1 Global Medicinal Radiocompounds Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Medicinal Radiocompounds Sales Quantity (2019-2030)
        1.5.3 Global Medicinal Radiocompounds Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Bracco Imaging
        2.1.1 Bracco Imaging Details
        2.1.2 Bracco Imaging Major Business
        2.1.3 Bracco Imaging Medicinal Radiocompounds Product and Services
        2.1.4 Bracco Imaging Medicinal Radiocompounds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Bracco Imaging Recent Developments/Updates
    2.2 Bayer
        2.2.1 Bayer Details
        2.2.2 Bayer Major Business
        2.2.3 Bayer Medicinal Radiocompounds Product and Services
        2.2.4 Bayer Medicinal Radiocompounds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Bayer Recent Developments/Updates
    2.3 Cardinal Health
        2.3.1 Cardinal Health Details
        2.3.2 Cardinal Health Major Business
        2.3.3 Cardinal Health Medicinal Radiocompounds Product and Services
        2.3.4 Cardinal Health Medicinal Radiocompounds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Cardinal Health Recent Developments/Updates
    2.4 Curium Pharma
        2.4.1 Curium Pharma Details
        2.4.2 Curium Pharma Major Business
        2.4.3 Curium Pharma Medicinal Radiocompounds Product and Services
        2.4.4 Curium Pharma Medicinal Radiocompounds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Curium Pharma Recent Developments/Updates
    2.5 Novartis
        2.5.1 Novartis Details
        2.5.2 Novartis Major Business
        2.5.3 Novartis Medicinal Radiocompounds Product and Services
        2.5.4 Novartis Medicinal Radiocompounds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Novartis Recent Developments/Updates
    2.6 Lantheus
        2.6.1 Lantheus Details
        2.6.2 Lantheus Major Business
        2.6.3 Lantheus Medicinal Radiocompounds Product and Services
        2.6.4 Lantheus Medicinal Radiocompounds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Lantheus Recent Developments/Updates
    2.7 Acrotech Biopharma
        2.7.1 Acrotech Biopharma Details
        2.7.2 Acrotech Biopharma Major Business
        2.7.3 Acrotech Biopharma Medicinal Radiocompounds Product and Services
        2.7.4 Acrotech Biopharma Medicinal Radiocompounds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Acrotech Biopharma Recent Developments/Updates
    2.8 GE Healthcare
        2.8.1 GE Healthcare Details
        2.8.2 GE Healthcare Major Business
        2.8.3 GE Healthcare Medicinal Radiocompounds Product and Services
        2.8.4 GE Healthcare Medicinal Radiocompounds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 GE Healthcare Recent Developments/Updates
    2.9 China Isotope & Radiation
        2.9.1 China Isotope & Radiation Details
        2.9.2 China Isotope & Radiation Major Business
        2.9.3 China Isotope & Radiation Medicinal Radiocompounds Product and Services
        2.9.4 China Isotope & Radiation Medicinal Radiocompounds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 China Isotope & Radiation Recent Developments/Updates
    2.10 Jubilant Pharma
        2.10.1 Jubilant Pharma Details
        2.10.2 Jubilant Pharma Major Business
        2.10.3 Jubilant Pharma Medicinal Radiocompounds Product and Services
        2.10.4 Jubilant Pharma Medicinal Radiocompounds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Jubilant Pharma Recent Developments/Updates
    2.11 Eli Lilly
        2.11.1 Eli Lilly Details
        2.11.2 Eli Lilly Major Business
        2.11.3 Eli Lilly Medicinal Radiocompounds Product and Services
        2.11.4 Eli Lilly Medicinal Radiocompounds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Eli Lilly Recent Developments/Updates
    2.12 SIEMENS
        2.12.1 SIEMENS Details
        2.12.2 SIEMENS Major Business
        2.12.3 SIEMENS Medicinal Radiocompounds Product and Services
        2.12.4 SIEMENS Medicinal Radiocompounds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 SIEMENS Recent Developments/Updates
    2.13 Dongcheng
        2.13.1 Dongcheng Details
        2.13.2 Dongcheng Major Business
        2.13.3 Dongcheng Medicinal Radiocompounds Product and Services
        2.13.4 Dongcheng Medicinal Radiocompounds Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 Dongcheng Recent Developments/Updates

3 Competitive Environment: Medicinal Radiocompounds by Manufacturer
    3.1 Global Medicinal Radiocompounds Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Medicinal Radiocompounds Revenue by Manufacturer (2019-2024)
    3.3 Global Medicinal Radiocompounds Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Medicinal Radiocompounds by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Medicinal Radiocompounds Manufacturer Market Share in 2023
        3.4.2 Top 6 Medicinal Radiocompounds Manufacturer Market Share in 2023
    3.5 Medicinal Radiocompounds Market: Overall Company Footprint Analysis
        3.5.1 Medicinal Radiocompounds Market: Region Footprint
        3.5.2 Medicinal Radiocompounds Market: Company Product Type Footprint
        3.5.3 Medicinal Radiocompounds Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Medicinal Radiocompounds Market Size by Region
        4.1.1 Global Medicinal Radiocompounds Sales Quantity by Region (2019-2030)
        4.1.2 Global Medicinal Radiocompounds Consumption Value by Region (2019-2030)
        4.1.3 Global Medicinal Radiocompounds Average Price by Region (2019-2030)
    4.2 North America Medicinal Radiocompounds Consumption Value (2019-2030)
    4.3 Europe Medicinal Radiocompounds Consumption Value (2019-2030)
    4.4 Asia-Pacific Medicinal Radiocompounds Consumption Value (2019-2030)
    4.5 South America Medicinal Radiocompounds Consumption Value (2019-2030)
    4.6 Middle East and Africa Medicinal Radiocompounds Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Medicinal Radiocompounds Sales Quantity by Type (2019-2030)
    5.2 Global Medicinal Radiocompounds Consumption Value by Type (2019-2030)
    5.3 Global Medicinal Radiocompounds Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Medicinal Radiocompounds Sales Quantity by Application (2019-2030)
    6.2 Global Medicinal Radiocompounds Consumption Value by Application (2019-2030)
    6.3 Global Medicinal Radiocompounds Average Price by Application (2019-2030)

7 North America
    7.1 North America Medicinal Radiocompounds Sales Quantity by Type (2019-2030)
    7.2 North America Medicinal Radiocompounds Sales Quantity by Application (2019-2030)
    7.3 North America Medicinal Radiocompounds Market Size by Country
        7.3.1 North America Medicinal Radiocompounds Sales Quantity by Country (2019-2030)
        7.3.2 North America Medicinal Radiocompounds Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Medicinal Radiocompounds Sales Quantity by Type (2019-2030)
    8.2 Europe Medicinal Radiocompounds Sales Quantity by Application (2019-2030)
    8.3 Europe Medicinal Radiocompounds Market Size by Country
        8.3.1 Europe Medicinal Radiocompounds Sales Quantity by Country (2019-2030)
        8.3.2 Europe Medicinal Radiocompounds Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Medicinal Radiocompounds Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Medicinal Radiocompounds Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Medicinal Radiocompounds Market Size by Region
        9.3.1 Asia-Pacific Medicinal Radiocompounds Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Medicinal Radiocompounds Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Medicinal Radiocompounds Sales Quantity by Type (2019-2030)
    10.2 South America Medicinal Radiocompounds Sales Quantity by Application (2019-2030)
    10.3 South America Medicinal Radiocompounds Market Size by Country
        10.3.1 South America Medicinal Radiocompounds Sales Quantity by Country (2019-2030)
        10.3.2 South America Medicinal Radiocompounds Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Medicinal Radiocompounds Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Medicinal Radiocompounds Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Medicinal Radiocompounds Market Size by Country
        11.3.1 Middle East & Africa Medicinal Radiocompounds Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Medicinal Radiocompounds Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Medicinal Radiocompounds Market Drivers
    12.2 Medicinal Radiocompounds Market Restraints
    12.3 Medicinal Radiocompounds Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Medicinal Radiocompounds and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Medicinal Radiocompounds
    13.3 Medicinal Radiocompounds Production Process
    13.4 Medicinal Radiocompounds Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Medicinal Radiocompounds Typical Distributors
    14.3 Medicinal Radiocompounds Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Medicinal Radiocompounds Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Medicinal Radiocompounds Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Bracco Imaging Basic Information, Manufacturing Base and Competitors
    Table 4. Bracco Imaging Major Business
    Table 5. Bracco Imaging Medicinal Radiocompounds Product and Services
    Table 6. Bracco Imaging Medicinal Radiocompounds Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. Bracco Imaging Recent Developments/Updates
    Table 8. Bayer Basic Information, Manufacturing Base and Competitors
    Table 9. Bayer Major Business
    Table 10. Bayer Medicinal Radiocompounds Product and Services
    Table 11. Bayer Medicinal Radiocompounds Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. Bayer Recent Developments/Updates
    Table 13. Cardinal Health Basic Information, Manufacturing Base and Competitors
    Table 14. Cardinal Health Major Business
    Table 15. Cardinal Health Medicinal Radiocompounds Product and Services
    Table 16. Cardinal Health Medicinal Radiocompounds Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. Cardinal Health Recent Developments/Updates
    Table 18. Curium Pharma Basic Information, Manufacturing Base and Competitors
    Table 19. Curium Pharma Major Business
    Table 20. Curium Pharma Medicinal Radiocompounds Product and Services
    Table 21. Curium Pharma Medicinal Radiocompounds Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. Curium Pharma Recent Developments/Updates
    Table 23. Novartis Basic Information, Manufacturing Base and Competitors
    Table 24. Novartis Major Business
    Table 25. Novartis Medicinal Radiocompounds Product and Services
    Table 26. Novartis Medicinal Radiocompounds Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. Novartis Recent Developments/Updates
    Table 28. Lantheus Basic Information, Manufacturing Base and Competitors
    Table 29. Lantheus Major Business
    Table 30. Lantheus Medicinal Radiocompounds Product and Services
    Table 31. Lantheus Medicinal Radiocompounds Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. Lantheus Recent Developments/Updates
    Table 33. Acrotech Biopharma Basic Information, Manufacturing Base and Competitors
    Table 34. Acrotech Biopharma Major Business
    Table 35. Acrotech Biopharma Medicinal Radiocompounds Product and Services
    Table 36. Acrotech Biopharma Medicinal Radiocompounds Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 37. Acrotech Biopharma Recent Developments/Updates
    Table 38. GE Healthcare Basic Information, Manufacturing Base and Competitors
    Table 39. GE Healthcare Major Business
    Table 40. GE Healthcare Medicinal Radiocompounds Product and Services
    Table 41. GE Healthcare Medicinal Radiocompounds Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 42. GE Healthcare Recent Developments/Updates
    Table 43. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
    Table 44. China Isotope & Radiation Major Business
    Table 45. China Isotope & Radiation Medicinal Radiocompounds Product and Services
    Table 46. China Isotope & Radiation Medicinal Radiocompounds Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 47. China Isotope & Radiation Recent Developments/Updates
    Table 48. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
    Table 49. Jubilant Pharma Major Business
    Table 50. Jubilant Pharma Medicinal Radiocompounds Product and Services
    Table 51. Jubilant Pharma Medicinal Radiocompounds Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 52. Jubilant Pharma Recent Developments/Updates
    Table 53. Eli Lilly Basic Information, Manufacturing Base and Competitors
    Table 54. Eli Lilly Major Business
    Table 55. Eli Lilly Medicinal Radiocompounds Product and Services
    Table 56. Eli Lilly Medicinal Radiocompounds Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 57. Eli Lilly Recent Developments/Updates
    Table 58. SIEMENS Basic Information, Manufacturing Base and Competitors
    Table 59. SIEMENS Major Business
    Table 60. SIEMENS Medicinal Radiocompounds Product and Services
    Table 61. SIEMENS Medicinal Radiocompounds Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 62. SIEMENS Recent Developments/Updates
    Table 63. Dongcheng Basic Information, Manufacturing Base and Competitors
    Table 64. Dongcheng Major Business
    Table 65. Dongcheng Medicinal Radiocompounds Product and Services
    Table 66. Dongcheng Medicinal Radiocompounds Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 67. Dongcheng Recent Developments/Updates
    Table 68. Global Medicinal Radiocompounds Sales Quantity by Manufacturer (2019-2024) & (Tons)
    Table 69. Global Medicinal Radiocompounds Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 70. Global Medicinal Radiocompounds Average Price by Manufacturer (2019-2024) & (US$/Ton)
    Table 71. Market Position of Manufacturers in Medicinal Radiocompounds, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 72. Head Office and Medicinal Radiocompounds Production Site of Key Manufacturer
    Table 73. Medicinal Radiocompounds Market: Company Product Type Footprint
    Table 74. Medicinal Radiocompounds Market: Company Product Application Footprint
    Table 75. Medicinal Radiocompounds New Market Entrants and Barriers to Market Entry
    Table 76. Medicinal Radiocompounds Mergers, Acquisition, Agreements, and Collaborations
    Table 77. Global Medicinal Radiocompounds Sales Quantity by Region (2019-2024) & (Tons)
    Table 78. Global Medicinal Radiocompounds Sales Quantity by Region (2025-2030) & (Tons)
    Table 79. Global Medicinal Radiocompounds Consumption Value by Region (2019-2024) & (USD Million)
    Table 80. Global Medicinal Radiocompounds Consumption Value by Region (2025-2030) & (USD Million)
    Table 81. Global Medicinal Radiocompounds Average Price by Region (2019-2024) & (US$/Ton)
    Table 82. Global Medicinal Radiocompounds Average Price by Region (2025-2030) & (US$/Ton)
    Table 83. Global Medicinal Radiocompounds Sales Quantity by Type (2019-2024) & (Tons)
    Table 84. Global Medicinal Radiocompounds Sales Quantity by Type (2025-2030) & (Tons)
    Table 85. Global Medicinal Radiocompounds Consumption Value by Type (2019-2024) & (USD Million)
    Table 86. Global Medicinal Radiocompounds Consumption Value by Type (2025-2030) & (USD Million)
    Table 87. Global Medicinal Radiocompounds Average Price by Type (2019-2024) & (US$/Ton)
    Table 88. Global Medicinal Radiocompounds Average Price by Type (2025-2030) & (US$/Ton)
    Table 89. Global Medicinal Radiocompounds Sales Quantity by Application (2019-2024) & (Tons)
    Table 90. Global Medicinal Radiocompounds Sales Quantity by Application (2025-2030) & (Tons)
    Table 91. Global Medicinal Radiocompounds Consumption Value by Application (2019-2024) & (USD Million)
    Table 92. Global Medicinal Radiocompounds Consumption Value by Application (2025-2030) & (USD Million)
    Table 93. Global Medicinal Radiocompounds Average Price by Application (2019-2024) & (US$/Ton)
    Table 94. Global Medicinal Radiocompounds Average Price by Application (2025-2030) & (US$/Ton)
    Table 95. North America Medicinal Radiocompounds Sales Quantity by Type (2019-2024) & (Tons)
    Table 96. North America Medicinal Radiocompounds Sales Quantity by Type (2025-2030) & (Tons)
    Table 97. North America Medicinal Radiocompounds Sales Quantity by Application (2019-2024) & (Tons)
    Table 98. North America Medicinal Radiocompounds Sales Quantity by Application (2025-2030) & (Tons)
    Table 99. North America Medicinal Radiocompounds Sales Quantity by Country (2019-2024) & (Tons)
    Table 100. North America Medicinal Radiocompounds Sales Quantity by Country (2025-2030) & (Tons)
    Table 101. North America Medicinal Radiocompounds Consumption Value by Country (2019-2024) & (USD Million)
    Table 102. North America Medicinal Radiocompounds Consumption Value by Country (2025-2030) & (USD Million)
    Table 103. Europe Medicinal Radiocompounds Sales Quantity by Type (2019-2024) & (Tons)
    Table 104. Europe Medicinal Radiocompounds Sales Quantity by Type (2025-2030) & (Tons)
    Table 105. Europe Medicinal Radiocompounds Sales Quantity by Application (2019-2024) & (Tons)
    Table 106. Europe Medicinal Radiocompounds Sales Quantity by Application (2025-2030) & (Tons)
    Table 107. Europe Medicinal Radiocompounds Sales Quantity by Country (2019-2024) & (Tons)
    Table 108. Europe Medicinal Radiocompounds Sales Quantity by Country (2025-2030) & (Tons)
    Table 109. Europe Medicinal Radiocompounds Consumption Value by Country (2019-2024) & (USD Million)
    Table 110. Europe Medicinal Radiocompounds Consumption Value by Country (2025-2030) & (USD Million)
    Table 111. Asia-Pacific Medicinal Radiocompounds Sales Quantity by Type (2019-2024) & (Tons)
    Table 112. Asia-Pacific Medicinal Radiocompounds Sales Quantity by Type (2025-2030) & (Tons)
    Table 113. Asia-Pacific Medicinal Radiocompounds Sales Quantity by Application (2019-2024) & (Tons)
    Table 114. Asia-Pacific Medicinal Radiocompounds Sales Quantity by Application (2025-2030) & (Tons)
    Table 115. Asia-Pacific Medicinal Radiocompounds Sales Quantity by Region (2019-2024) & (Tons)
    Table 116. Asia-Pacific Medicinal Radiocompounds Sales Quantity by Region (2025-2030) & (Tons)
    Table 117. Asia-Pacific Medicinal Radiocompounds Consumption Value by Region (2019-2024) & (USD Million)
    Table 118. Asia-Pacific Medicinal Radiocompounds Consumption Value by Region (2025-2030) & (USD Million)
    Table 119. South America Medicinal Radiocompounds Sales Quantity by Type (2019-2024) & (Tons)
    Table 120. South America Medicinal Radiocompounds Sales Quantity by Type (2025-2030) & (Tons)
    Table 121. South America Medicinal Radiocompounds Sales Quantity by Application (2019-2024) & (Tons)
    Table 122. South America Medicinal Radiocompounds Sales Quantity by Application (2025-2030) & (Tons)
    Table 123. South America Medicinal Radiocompounds Sales Quantity by Country (2019-2024) & (Tons)
    Table 124. South America Medicinal Radiocompounds Sales Quantity by Country (2025-2030) & (Tons)
    Table 125. South America Medicinal Radiocompounds Consumption Value by Country (2019-2024) & (USD Million)
    Table 126. South America Medicinal Radiocompounds Consumption Value by Country (2025-2030) & (USD Million)
    Table 127. Middle East & Africa Medicinal Radiocompounds Sales Quantity by Type (2019-2024) & (Tons)
    Table 128. Middle East & Africa Medicinal Radiocompounds Sales Quantity by Type (2025-2030) & (Tons)
    Table 129. Middle East & Africa Medicinal Radiocompounds Sales Quantity by Application (2019-2024) & (Tons)
    Table 130. Middle East & Africa Medicinal Radiocompounds Sales Quantity by Application (2025-2030) & (Tons)
    Table 131. Middle East & Africa Medicinal Radiocompounds Sales Quantity by Region (2019-2024) & (Tons)
    Table 132. Middle East & Africa Medicinal Radiocompounds Sales Quantity by Region (2025-2030) & (Tons)
    Table 133. Middle East & Africa Medicinal Radiocompounds Consumption Value by Region (2019-2024) & (USD Million)
    Table 134. Middle East & Africa Medicinal Radiocompounds Consumption Value by Region (2025-2030) & (USD Million)
    Table 135. Medicinal Radiocompounds Raw Material
    Table 136. Key Manufacturers of Medicinal Radiocompounds Raw Materials
    Table 137. Medicinal Radiocompounds Typical Distributors
    Table 138. Medicinal Radiocompounds Typical Customers
List of Figures
    Figure 1. Medicinal Radiocompounds Picture
    Figure 2. Global Medicinal Radiocompounds Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Medicinal Radiocompounds Consumption Value Market Share by Type in 2023
    Figure 4. Technetium 99 Examples
    Figure 5. Fluorine 18 Examples
    Figure 6. Other Examples
    Figure 7. Global Medicinal Radiocompounds Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 8. Global Medicinal Radiocompounds Consumption Value Market Share by Application in 2023
    Figure 9. Oncology Examples
    Figure 10. Cardiology Examples
    Figure 11. Others Examples
    Figure 12. Global Medicinal Radiocompounds Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 13. Global Medicinal Radiocompounds Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 14. Global Medicinal Radiocompounds Sales Quantity (2019-2030) & (Tons)
    Figure 15. Global Medicinal Radiocompounds Average Price (2019-2030) & (US$/Ton)
    Figure 16. Global Medicinal Radiocompounds Sales Quantity Market Share by Manufacturer in 2023
    Figure 17. Global Medicinal Radiocompounds Consumption Value Market Share by Manufacturer in 2023
    Figure 18. Producer Shipments of Medicinal Radiocompounds by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 19. Top 3 Medicinal Radiocompounds Manufacturer (Consumption Value) Market Share in 2023
    Figure 20. Top 6 Medicinal Radiocompounds Manufacturer (Consumption Value) Market Share in 2023
    Figure 21. Global Medicinal Radiocompounds Sales Quantity Market Share by Region (2019-2030)
    Figure 22. Global Medicinal Radiocompounds Consumption Value Market Share by Region (2019-2030)
    Figure 23. North America Medicinal Radiocompounds Consumption Value (2019-2030) & (USD Million)
    Figure 24. Europe Medicinal Radiocompounds Consumption Value (2019-2030) & (USD Million)
    Figure 25. Asia-Pacific Medicinal Radiocompounds Consumption Value (2019-2030) & (USD Million)
    Figure 26. South America Medicinal Radiocompounds Consumption Value (2019-2030) & (USD Million)
    Figure 27. Middle East & Africa Medicinal Radiocompounds Consumption Value (2019-2030) & (USD Million)
    Figure 28. Global Medicinal Radiocompounds Sales Quantity Market Share by Type (2019-2030)
    Figure 29. Global Medicinal Radiocompounds Consumption Value Market Share by Type (2019-2030)
    Figure 30. Global Medicinal Radiocompounds Average Price by Type (2019-2030) & (US$/Ton)
    Figure 31. Global Medicinal Radiocompounds Sales Quantity Market Share by Application (2019-2030)
    Figure 32. Global Medicinal Radiocompounds Consumption Value Market Share by Application (2019-2030)
    Figure 33. Global Medicinal Radiocompounds Average Price by Application (2019-2030) & (US$/Ton)
    Figure 34. North America Medicinal Radiocompounds Sales Quantity Market Share by Type (2019-2030)
    Figure 35. North America Medicinal Radiocompounds Sales Quantity Market Share by Application (2019-2030)
    Figure 36. North America Medicinal Radiocompounds Sales Quantity Market Share by Country (2019-2030)
    Figure 37. North America Medicinal Radiocompounds Consumption Value Market Share by Country (2019-2030)
    Figure 38. United States Medicinal Radiocompounds Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 39. Canada Medicinal Radiocompounds Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 40. Mexico Medicinal Radiocompounds Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 41. Europe Medicinal Radiocompounds Sales Quantity Market Share by Type (2019-2030)
    Figure 42. Europe Medicinal Radiocompounds Sales Quantity Market Share by Application (2019-2030)
    Figure 43. Europe Medicinal Radiocompounds Sales Quantity Market Share by Country (2019-2030)
    Figure 44. Europe Medicinal Radiocompounds Consumption Value Market Share by Country (2019-2030)
    Figure 45. Germany Medicinal Radiocompounds Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 46. France Medicinal Radiocompounds Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 47. United Kingdom Medicinal Radiocompounds Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. Russia Medicinal Radiocompounds Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 49. Italy Medicinal Radiocompounds Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 50. Asia-Pacific Medicinal Radiocompounds Sales Quantity Market Share by Type (2019-2030)
    Figure 51. Asia-Pacific Medicinal Radiocompounds Sales Quantity Market Share by Application (2019-2030)
    Figure 52. Asia-Pacific Medicinal Radiocompounds Sales Quantity Market Share by Region (2019-2030)
    Figure 53. Asia-Pacific Medicinal Radiocompounds Consumption Value Market Share by Region (2019-2030)
    Figure 54. China Medicinal Radiocompounds Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 55. Japan Medicinal Radiocompounds Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 56. Korea Medicinal Radiocompounds Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. India Medicinal Radiocompounds Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. Southeast Asia Medicinal Radiocompounds Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 59. Australia Medicinal Radiocompounds Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 60. South America Medicinal Radiocompounds Sales Quantity Market Share by Type (2019-2030)
    Figure 61. South America Medicinal Radiocompounds Sales Quantity Market Share by Application (2019-2030)
    Figure 62. South America Medicinal Radiocompounds Sales Quantity Market Share by Country (2019-2030)
    Figure 63. South America Medicinal Radiocompounds Consumption Value Market Share by Country (2019-2030)
    Figure 64. Brazil Medicinal Radiocompounds Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 65. Argentina Medicinal Radiocompounds Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 66. Middle East & Africa Medicinal Radiocompounds Sales Quantity Market Share by Type (2019-2030)
    Figure 67. Middle East & Africa Medicinal Radiocompounds Sales Quantity Market Share by Application (2019-2030)
    Figure 68. Middle East & Africa Medicinal Radiocompounds Sales Quantity Market Share by Region (2019-2030)
    Figure 69. Middle East & Africa Medicinal Radiocompounds Consumption Value Market Share by Region (2019-2030)
    Figure 70. Turkey Medicinal Radiocompounds Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 71. Egypt Medicinal Radiocompounds Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 72. Saudi Arabia Medicinal Radiocompounds Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 73. South Africa Medicinal Radiocompounds Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 74. Medicinal Radiocompounds Market Drivers
    Figure 75. Medicinal Radiocompounds Market Restraints
    Figure 76. Medicinal Radiocompounds Market Trends
    Figure 77. Porters Five Forces Analysis
    Figure 78. Manufacturing Cost Structure Analysis of Medicinal Radiocompounds in 2023
    Figure 79. Manufacturing Process Analysis of Medicinal Radiocompounds
    Figure 80. Medicinal Radiocompounds Industrial Chain
    Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 82. Direct Channel Pros & Cons
    Figure 83. Indirect Channel Pros & Cons
    Figure 84. Methodology
    Figure 85. Research Process and Data Source

Companies Mentioned

Bracco Imaging
Bayer
Cardinal Health
Curium Pharma
Novartis
Lantheus
Acrotech Biopharma
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
SIEMENS
Dongcheng